
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
Lung Cancer Update
00:00
The Importance of PDL1 Expression in Adjuvant Therapy
I do think that the PDL1 level is important and I think that we're more likely to help people who have IPEDL1 levels. We can give people lifelong toxicity especially you know under kunapa these are the most common that we see in that setting so trying to weigh what is the probability I'm actually going to help this patient versus that probability I'm going to cause harm was really always the main question for me. Lewis about this step four that we've made now with a really prolonged survival benefit that's now completely gotten into the community setting any thoughts in kind of putting this in perspective in terms of what this trial really is meant to this field yeah.
Transcript
Play full episode